Keel Point’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,569
| Closed | -$100K | – | 260 |
|
|
2022
Q1 | $100K | Hold |
14,569
| – | – | 0.02% | 256 |
|
|
2021
Q4 | $118K | Sell |
14,569
-41,500
| -74% | -$336K | 0.01% | 259 |
|
|
2021
Q3 | $549K | Sell |
56,069
-51,551
| -48% | -$505K | 0.07% | 140 |
|
|
2021
Q2 | $724K | Buy |
107,620
+64,569
| +150% | +$434K | 0.08% | 132 |
|
|
2021
Q1 | $389K | Sell |
43,051
-49,173
| -53% | -$444K | 0.04% | 170 |
|
|
2020
Q4 | $616K | Hold |
92,224
| – | – | 0.05% | 135 |
|
|
2020
Q3 | $465K | Buy |
92,224
+20,000
| +28% | +$101K | 0.04% | 138 |
|
|
2020
Q2 | $584K | Buy |
72,224
+1,551
| +2% | +$12.5K | 0.06% | 111 |
|
|
2020
Q1 | $561K | Buy |
70,673
+30,673
| +77% | +$243K | 0.07% | 106 |
|
|
2019
Q4 | $302K | Buy |
+40,000
| New | +$302K | 0.03% | 156 |
|